Erythrasma physical examination: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Erythrasma}} | {{Erythrasma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{KS}}, {{LRO}} | ||
{{ | |||
==Overview== | ==Overview== | ||
Erythrasma presents with [[erythema|erythematous]] [[lesions]], [[maceration]], and reddish-brown scales indicative of [[hyperkeratosis]]. The lesions are usually found in [[skin folds]], and also commonly present in the interdigital regions in hands and feet. Erythrasma patients are usually well-appearing, barring complications. | |||
==Physical Examination== | ==Physical Examination== | ||
===Appearance of the Patient=== | |||
*The patient is usually well-appearing.<ref name="urlErythrasma: MedlinePlus Medical Encyclopedia">{{cite web |url=https://medlineplus.gov/ency/article/001470.htm |title=Erythrasma: MedlinePlus Medical Encyclopedia |format= |work= |accessdate=}}</ref> | |||
===Skin=== | |||
*Erythrasma presents with [[erythema|erythematous]] [[lesion]], [[maceration]], and reddish-brown scales indicative of [[hyperkeratosis]].<ref name="pmid27294050">{{cite journal |vauthors=Pinto M, Hundi GK, Bhat RM, Bala NK, Dandekeri S, Martis J, Kambil SM |title=Clinical and epidemiological features of coryneform skin infections at a tertiary hospital |journal=Indian Dermatol Online J |volume=7 |issue=3 |pages=168–73 |year=2016 |pmid=27294050 |pmc=4886587 |doi=10.4103/2229-5178.182351 |url=}}</ref> | |||
**The borders of the [[lesions]] and unaffected skin are sharply demarcated. | |||
**The lesions are usually found in [[skin folds]]. | |||
===Extremities=== | |||
*Erythrasma commonly presents in the interdigital regions in hands and feet.<ref name="pmid12010076">{{cite journal |vauthors=Holdiness MR |title=Management of cutaneous erythrasma |journal=Drugs |volume=62 |issue=8 |pages=1131–41 |year=2002 |pmid=12010076 |doi= |url=}}</ref> | |||
==Gallery== | |||
===Skin=== | ===Skin=== | ||
====Axilla==== | ====Axilla==== | ||
| Line 42: | Line 54: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Dermatology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 21:39, 29 July 2020
|
Erythrasma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erythrasma physical examination On the Web |
|
American Roentgen Ray Society Images of Erythrasma physical examination |
|
Risk calculators and risk factors for Erythrasma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2], Luke Rusowicz-Orazem, B.S.
Overview
Erythrasma presents with erythematous lesions, maceration, and reddish-brown scales indicative of hyperkeratosis. The lesions are usually found in skin folds, and also commonly present in the interdigital regions in hands and feet. Erythrasma patients are usually well-appearing, barring complications.
Physical Examination
Appearance of the Patient
- The patient is usually well-appearing.[1]
Skin
- Erythrasma presents with erythematous lesion, maceration, and reddish-brown scales indicative of hyperkeratosis.[2]
- The borders of the lesions and unaffected skin are sharply demarcated.
- The lesions are usually found in skin folds.
Extremities
- Erythrasma commonly presents in the interdigital regions in hands and feet.[3]
Gallery
Skin
Axilla
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/7/72/Erytrasma01.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/9/9c/Erytrasma02.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/0/0d/Erytrasma03.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/d/d9/Erytrasma04.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/1/14/Erytrasma05.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/5/5b/Erytrasma06.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/4/42/Erytrasma07.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma01.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma02.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma03.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma04.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma05.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma06.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma07.jpg)
Groin
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/4/41/Erytrasma08.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/b/bd/Erytrasma09.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
-
![Erytrasma. Adapted from Dermatology Atlas.[4]](/images/4/40/Erytrasma10.jpg)
Erytrasma. Adapted from Dermatology Atlas.[4]
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma08.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma09.jpg)
![Erytrasma. Adapted from Dermatology Atlas.[4]](/index.php/File:Erytrasma10.jpg)
References
- ↑ "Erythrasma: MedlinePlus Medical Encyclopedia".
- ↑ Pinto M, Hundi GK, Bhat RM, Bala NK, Dandekeri S, Martis J, Kambil SM (2016). "Clinical and epidemiological features of coryneform skin infections at a tertiary hospital". Indian Dermatol Online J. 7 (3): 168–73. doi:10.4103/2229-5178.182351. PMC 4886587. PMID 27294050.
- ↑ Holdiness MR (2002). "Management of cutaneous erythrasma". Drugs. 62 (8): 1131–41. PMID 12010076.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 "Dermatology Atlas".